Non-human mammals and their progenies comprising an integrin alpha10 gene, integrin alpha11 gene, or both genes are provided, wherein at least a part of the integrin alpha10 gene, the integrin alpha11 gene, or both genes, of said non-human mammal and its progeny has/have been replaced with a DNA sequence comprising at least a portion of one exon of the integrin alpha10 coding sequence, the integrin alpha11 coding sequence, or both coding sequences, linked to a selection marker sequence. Also included are methods for generating said non-human mammals with a disrupted alpha10 gene, a disrupted alpha11 gene or both genes disrupted, as well as the use of said non-human mammals.

 
Web www.patentalert.com

< ISOROM portable isometric and passive range of motion device

< Method for muscle delivery of drugs, nucleic acids and other compounds

> Pharmaceutical composition and method for treating disorders of the central nervous system

> Pyrrolopyridine derivative and use thereof

~ 00266